This guideline covers how to identify the adults, young people and children with non-alcoholic fatty liver disease (NAFLD) who have advanced liver fibrosis and are most at risk of further complications. It outlines the lifestyle changes and pharmacological treatments that can manage NAFLD and advanced li...
Pai, M;
Key, NS;
Skinner, M;
Curtis, R;
Feinstein, M;
Kessler, C;
Lane, SJ;
Makris, M;
Riker, E;
Santesso, N;
Soucie, JM;
Yeung, CH;
Iorio, A;
Schünemann, HJ.
This guideline was developed to identify evidence-based best practices in haemophilia care delivery, and discuss the range of care providers and services that are most important to optimize outcomes for persons with haemophilia (PWH) across the United States. The guideline was developed following specifi...
Dent, S;
Brezden-Masley, C;
Clarke, B;
Davis, MK;
Jassal, DS;
Johnson, C;
Lemieux, J;
Paterson, I;
Sebag, IA;
Simmons, C;
Sulpher, J;
Thain, K;
Thavendiranathan, P;
Wentzell, JR;
Wurtele, N;
Côté, MA;
Fine, NM;
Haddad, H;
Hayley, BD;
Hopkins, S;
Joy, AA;
Rayson, D;
Stadnick, E;
Straatman, L;
Virani, SA.
Modern treatment strategies have led to improvements in cancer survival, however, these gains might be offset by the potential negative effect of cancer therapy on cardiovascular health. Cardiotoxicity is now recognized as a leading cause of long-term morbidity and mortality among cancer survivors. This ...
Antineoplásicos,
Biomarcadores,
Cardiotónicos,
Cardiotoxinas,
Troponina T,
Péptido Natriurético Encefálico,
Proteína C-Reactiva,
Antineoplásicos/efectos adversos,
Arritmias Cardíacas,
Cardiotoxicidad,
Trombosis Coronaria,
Diagnóstico Precoz,
Ecocardiografía Tridimensional,
Hipertensión/terapia,
Imagen por Resonancia Cinemagnética,
Isquemia Miocárdica,
Neoplasias/terapia,
Prevención Primaria,
Radioterapia,
Factores de Riesgo,
Disfunción Ventricular Izquierda,
Cardiotoxicidad/diagnóstico,
Cardiotoxinas/efectos adversos,
Radioterapia/efectos adversos
Forner, A;
Reig, M;
Varela, M;
Burrel, M;
Feliu, J;
Briceño, J;
Sastre, J;
Martí-Bonmati, L;
Llovet, JM;
Bilbao, JI;
Sangro, B;
Pardo, F;
Ayuso, C;
Bru, C;
Tabernero, J;
Bruix, J.
Hepatocellular carcinoma is the most common primary malignancy of the liver and one of the most frequent causes of death in patients with liver cirrhosis. Simultaneously with the recognition of the clinical relevance of this neoplasm, in recent years there have been important developments in the diagnosi...
Este documento abarca temas de diagnóstico y manejo de dengue con y sin signos de alarma....
Turck, D;
Braegger, CP;
Colombo, C;
Declercq, D;
Morton, A;
Pancheva, R;
Robberecht, E;
Stern, M;
Strandvik, B;
Wolfe, S;
Schneider, SM;
Wilschanski, M.
"BACKGROUND:
Malnutrition is both a frequent feature and a comorbidity of cystic fibrosis (CF), with nutritional status strongly associated with pulmonary function and survival. Nutritional management is therefore standard of care in CF patients. ESPEN, ESPGHAN and ECFS recommended guidelines to cover nu...
Terapia Combinada,
Consenso,
Fibrosis Quística,
Suplementos Dietéticos,
Progresión de la Enfermedad,
Fibrosis Quística/terapia,
Dieta Saludable,
Síndromes de Malabsorción,
Desnutrición,
Apoyo Nutricional,
Desnutrición/prevención & control,
Medicina de Precisión,
Fibrosis Quística/dietoterapia
OBJECTIVE:
To develop clinical practice guidelines for the management of patients with primary aldosteronism.
PARTICIPANTS:
The Task Force included a chair, selected by the Clinical Guidelines Subcommittee of the Endocrine Society, six additional experts, a methodologist, and a medical writer. The guide...
Vranešić, Bender, D;
Giljević, Z;
Kušec, V;
Laktašic Žerjavić, N;
Bošnjak Pašic, M;
Vrdoljak, E;
Lkinas Kelećić, Dina;
Reiner, Ž;
Anić, B;
Krznarić, Ž.
It is estimated that over one billion of people around the globe have low serum values of vitamin D, therefore, we can consider vitamin D deficiency as a pandemic and public health problem. Geographic position of Croatia, especially the continental part of the country, is a risk factor for the developmen...
Contribuir a la reducción de la morbilidad de las personas con pie diabético. Establecer criterios técnicos para el diagnóstico, tratamiento y control del pie
diabético en personas con diabetes mellitus tipo 1 y 2 en el primer nivel de
atención. La presente guía técnica tiene como ámbito de apli...
